Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells

D Puthier, S Derenne, S Barillé… - British journal of …, 1999 - Wiley Online Library
D Puthier, S Derenne, S Barillé, P Moreau, JL Harousseau, R Bataille, M Amiot
British journal of haematology, 1999Wiley Online Library
Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells
accumulate within the bone marrow. The expression of several anti‐apoptotic proteins was
evaluated by immunoblotting in human myeloma cell lines and in highly purified native
myeloma cells. Expression of Bcl‐xL, Mcl‐1 and Bcl‐2 was found in most of the samples;
expression of Bcl‐xL and Mcl‐1 seemed to be related on myeloma cells. In a system of
apoptosis by growth factor deprivation on myeloma cells, we showed that the effect of Bcl‐2 …
Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells accumulate within the bone marrow. The expression of several anti‐apoptotic proteins was evaluated by immunoblotting in human myeloma cell lines and in highly purified native myeloma cells. Expression of Bcl‐xL, Mcl‐1 and Bcl‐2 was found in most of the samples; expression of Bcl‐xL and Mcl‐1 seemed to be related on myeloma cells. In a system of apoptosis by growth factor deprivation on myeloma cells, we showed that the effect of Bcl‐2 seemed minimal whereas Mcl‐1 and Bcl‐xL were tightly regulated by interleukin (IL)‐6. These findings underline the important role of Mcl‐1 and Bcl‐xL instead of Bcl‐2 in IL‐6‐induced survival of myeloma cells.
Wiley Online Library